Improving Aspirin Prescription Rates in Outpatient Clinic
- Conditions
- Low Birth WeightSmall for Gestational Age (SGA)Preeclampsia (PE)Prevention &Amp; Control
- Interventions
- Registration Number
- NCT06694233
- Lead Sponsor
- Cairo University
- Brief Summary
Ρrееςlаmpѕia is a syndrome characterised by the new onset of hуреrtеnѕion plus proteinuria, end-organ dysfunction, or both after 20 weeks of gestation. It complicates 3-5% of pregnancies.
Low-dose aspirin reduces the frequency of рrееςlampsia, as well as related adverse рrеgոaոcy outcomes (preterm birth, growth restriction), by 10 to 70% when taken by patients аt moderate to high risk of the disease. It has an excellent maternal/fetal safety profile. Thus, it is a reasonable preventive strategy for these patients.
A pilot study at our hospital found that not all patients who are candidates for aspirin prescription receive it (only 40%). This audit cycle aims to increase aspirin prescription rates for moderate and high-risk obstetric populations.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Female
- Target Recruitment
- 300
Women at high risk are those with any of the following:
- hypertensive disease during a previous pregnancy
- chronic kidney disease
- autoimmune disease such as systemic lupus erythematosus or antiphospholipid syndrome
- type 1 or type 2 diabetes
- chronic hypertension.
Women with more than one moderate risk factor, such as are:
- nulliparity
- age 40 years or older
- pregnancy interval of more than 10 years
- body mass index (BMI) of 35 kg/m2 or more at first visit
- family history of pre-eclampsia
- multi-fetal pregnancy.
- None. All eligible candidates will be included.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Obstetric population candidate for aspirin prescription Aspirin prescription on outpatient basis Moderate- and high-risk obstetric population
- Primary Outcome Measures
Name Time Method Aspirin prescription Six months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Adan hospital
🇰🇼Hadiya, Ahmadi, Kuwait